Literature DB >> 32097663

A review on anti-cancer properties of Quercetin in breast cancer.

Maryam Ezzati1, Bahman Yousefi2, Kobra Velaei3, Amin Safa4.   

Abstract

Breast cancer is one of the well-known malignant tumors among women. In spite of attempts to classifying breast cancer according to its histological and molecular properties, it is almost considered as a dilemma in treatment. Nowadays, public and medical attentions have primary focused on foods with anti-cancer properties to alleviate the cancer problems. Flavonoid components such as Quercetin (Qu) as dietary substances with high attention of ordinary people might provide potential of alternative or complementary medicine in breast cancer. With regard to the wide range of health benefits of Qu, researchers have been generally convinced to bring Qu as natural compounds in cancer therapy. Moreover, the high cost of standard cancer treatments and the failure of most conventional treatments have led the medical community to pursue cost-effective prevention and treatment. As a result, a great deal of concentration is attracted to diet/cancer reciprocal action. Therefore, this review study has aimed to identify what has revealed the critical properties of Qu such as anti-inflammatory, anti-oxidant, and even its effect on proliferation, angiogenesis, or apoptosis that are considered as anti-tumor property to enhance breast cancer treatment.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Antioxidant; Apoptosis; Breast cancer; Proliferation; Quercetin

Year:  2020        PMID: 32097663     DOI: 10.1016/j.lfs.2020.117463

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  42 in total

Review 1.  Melatonin and its mechanism of action in the female reproductive system and related malignancies.

Authors:  Maryam Ezzati; Kobra Velaei; Raziyeh Kheirjou
Journal:  Mol Cell Biochem       Date:  2021-04-17       Impact factor: 3.396

Review 2.  Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies.

Authors:  Chandra Prakash; Jyoti Tyagi; Shyam Sunder Rabidas; Vijay Kumar; Deepak Sharma
Journal:  Neuromolecular Med       Date:  2022-08-11       Impact factor: 4.103

Review 3.  Dietary phytochemicals/nutrients as promising protector of breast cancer development: a comprehensive analysis.

Authors:  Suman Kumar Samanta; Paramita Choudhury; Partha Pratim Sarma; Bhaskarjyoti Gogoi; Neelutpal Gogoi; Rajlakshmi Devi
Journal:  Pharmacol Rep       Date:  2022-06-04       Impact factor: 3.919

Review 4.  Allium Vegetables Intake and Risk of Breast Cancer: A Meta-Analysis.

Authors:  Jinhang Zhang; Jing Yang
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

5.  Quercetin ameliorates Di (2-ethylhexyl) phthalate-induced nephrotoxicity by inhibiting NF-κB signaling pathway.

Authors:  Sorour Ashari; Mohammad Karami; Mohammad Shokrzadeh; Abouzar Bagheri; Morteza Ghandadi; Mohammad Ranaee; Ayat Dashti; Hamidreza Mohammadi
Journal:  Toxicol Res (Camb)       Date:  2022-03-03       Impact factor: 2.680

6.  Comparison of Anticancer Activity of Dorycnium pentaphyllum Extract on MCF-7 and MCF-12A Cell Line: Correlation with Invasion and Adhesion.

Authors:  Gözde Koygun; Emine Arslan; Gökhan Zengin; Giustino Orlando; Claudio Ferrante
Journal:  Biomolecules       Date:  2021-04-30

7.  Solid Lipid Nanoparticles Produced via a Coacervation Method as Promising Carriers for Controlled Release of Quercetin.

Authors:  Luigi Talarico; Marco Consumi; Gemma Leone; Gabriella Tamasi; Agnese Magnani
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

8.  Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy.

Authors:  Hawa Nordin Siti; Juriyati Jalil; Ahmad Yusof Asmadi; Yusof Kamisah
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  Quercetin Synergistically Enhances the Anticancer Efficacy of Docetaxel through Induction of Apoptosis and Modulation of PI3K/AKT, MAPK/ERK, and JAK/STAT3 Signaling Pathways in MDA-MB-231 Breast Cancer Cell Line.

Authors:  Amir Safi; Esfandiar Heidarian; Reza Ahmadi
Journal:  Int J Mol Cell Med       Date:  2021-05-22

10.  Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.

Authors:  Xingchao Xu; Jimei Zhang; Zhenhua Zhang; Meng Wang; Yaping Liu; Xiangqi Li
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.